Erythropoietin and Cardiocirculatory Condition in Aged Patients with Chronic Rena l Failure
2001
Background/Aim: The clearest benefit of recombinant human erythropoietin (rHuEPO) in end-stage renal disease is a substantial reduction in transfusion dependency and an improved qua
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
7
References
12
Citations
NaN
KQI